AAAAAA

   
Results: 1-8 |
Results: 8
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer
Authors: Kosmas, C Tsavaris, NB Malamos, NA Vadiaka, M Koufos, C
Citation: C. Kosmas et al., Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer, J CL ONCOL, 19(1), 2001, pp. 119-126
Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review
Authors: Kosmas, C Malamos, NA Tsavaris, N Antonopoulos, M
Citation: C. Kosmas et al., Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review, J NEURO-ONC, 47(2), 2000, pp. 161-165
Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy
Authors: Kosmas, C Malamos, NA Antonopoulos, M
Citation: C. Kosmas et al., Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy, MED PED ONC, 34(3), 2000, pp. 229-230
A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma
Authors: Kosmas, C Tsavaris, NB Polyzos, A Kalofonos, HP Sepsas, E Malamos, NA Vadiaka, M Dosios, T Antonopoulos, MJ
Citation: C. Kosmas et al., A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma, CANCER, 89(4), 2000, pp. 774-782
Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
Authors: Kosmas, C Tsavaris, NB Polyzos, A Malamos, NA Katsikas, M Antonopoulos, MJ
Citation: C. Kosmas et al., Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours, BR J CANC, 82(2), 2000, pp. 300-307
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin
Authors: Stathopoulos, GP Rigatos, S Malamos, NA
Citation: Gp. Stathopoulos et al., Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin, ONCOL REP, 6(4), 1999, pp. 797-800
Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment
Authors: Stathopoulos, GP Dafni, UG Malamos, NA Rigatos, S Kouvatseas, G Moschopoulos, N
Citation: Gp. Stathopoulos et al., Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment, ANTICANC R, 19(4C), 1999, pp. 3543-3548
Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: A potential free oxygen radical scavenger
Authors: Stathopoulos, GP Malamos, NA Dontas, I Deliconstantinos, G Perrea-Kotsareli, D Karayannacos, PE
Citation: Gp. Stathopoulos et al., Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: A potential free oxygen radical scavenger, ANTICANC R, 18(6A), 1998, pp. 4387-4392
Risultati: 1-8 |